Skip to main content

Pulmatrix, Inc.

PULM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001574235

No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Pulmatrix, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of PULM: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders2822−6
Shares7.09M7.96M+877.2K (+12.4%)
Value$9.42M$8.28M−$1.14M (−12.1%)

New holders (3)

Institutions that held Pulmatrix, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to PULM in Q2 2021
InstitutionSharesValue% of portfolio
State Street Corp276,823$288.0K0.00%
Virtu Financial LLC19,064$20.0K0.00%
ExodusPoint Capital Management, LP14,608$15.0K0.00%

Sold out (9)

Institutions that held Pulmatrix, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of PULM in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Millennium Management LLC94,032$125.0K
Hussman Strategic Advisors, Inc.72,000$96.0K
Citadel Advisors LLC35,386$47.0K
Charles Schwab Investment Management Inc29,584$40.0K
Two Sigma Advisers, LP25,500$34.0K
Squarepoint Ops LLC20,534$27.0K
Tower Research Capital LLC (TRC)18,714$25.0K
HighTower Advisors, LLC10,133$13.0K
Total Clarity Wealth Management, Inc.4,810$6.00K